Atrial Fibrillation and Clinical Outcomes Following Mitral Transcatheter Edge-to-Edge Repair According to Mitral Regurgitation Etiology

Read full text
Authors: Tetsu Tanaka, Masaki Izumo, Shingo Kuwata, Taishi Okuno, Daisuke Miyahara, Yoshihiro J. Akashi, Masanori Yamamoto, Shunsuke Kubo, Mike Saji, Yuki Izumi, Yusuke Enta, Shinichi Shirai
+15 more Shingo Mizuno, Yusuke Watanabe, Makoto Amaki, Kazuhisa Kodama, Junichi Yamaguchi, Toru Naganuma, Hiroki Bota, Yohei Ohno, Masahiko Asami, Daisuke Hachinohe, Masahiro Yamawaki, Hiroshi Ueno, Kazuki Mizutani, Toshiaki Otsuka, Kentaro Hayashida
Cited by: 1
References: 31

Abstract

BACKGROUND: The association between atrial fibrillation (AF) and prognosis after mitral transcatheter edge-to-edge repair (M-TEER) remains unclear. OBJECTIVES: The authors examined the association between AF and clinical outcomes after M-TEER according to the etiology of mitral regurgitation (MR). METHODS: A total of 3,764 patients were classified into degenerative mitral regurgitation (DMR), ventricular functional mitral regurgitation (VFMR), and atrial functional mitral regurgitation (AFMR). We further stratified the patients by the presence of AF. The primary outcome was all-cause mortality within 2 years. RESULTS: The prevalence of AF was 57.4% (n = 646 of 1,126) in DMR, 59.7% (n = 1,319 of 2,211) in VFMR, and 83.8% (n = 358 of 427) in AFMR. During 2-year follow-up (the median follow-up: 427 [IQR: 301-821] days), 660 of 3,764 patients (17.5%) died. The association between AF and all-cause mortality had a significant interaction with MR etiology (P for interaction

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Atrial Fibrillation Management and Outcomes Cardiovascular Function and Risk Factors

Publication details

Journal / source
JACC Asia
Publisher
Elsevier BV
Volume
6
Issue
8
Pages
1370–1381
Publication date
6 May 2026
Language
EN